Aiming to treat β-thalassemia and sickle cell disease with gene-edited hematopoietic stem cells
Creating the next generation of cell therapies for cancer enabled by gene editing
Mar 14, 2023
CRISPR Therapeutics to Present at the American Association for Cancer Research 2023 Annual Meeting
Mar 13, 2023
CRISPR Therapeutics Announces Transition of Chief Financial Officer
Feb 27, 2023
CRISPR Therapeutics to Participate in the 43rd Annual Cowen Health Care Conference
Join Our Team
We're looking for energetic, collaborative and talented people who like challenges, want to make a difference and have a track record of delivering results. View open opportunities
You are now leaving the CRISPR Therapeutics website.
CRISPR Therapeutics is not responsible for the content or availability of third-party sites.